Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer

Completed · Phase 2

Conditions studied: Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer

In brief

The purpose of this study is to determine the progression-free survival of patients with surgically staged, Stage I-II papillary serous, clear cell, or endometrioid carcinomas with high-intermediate risk factors treated by vaginal cuff brachytherapy followed by chemotherapy.

Key facts

Study ID

NCT00542490

Run by

University of Oklahoma

People needed

23

Starts

2007-09-01

Expected to finish

2016-02-01

Last updated by the study team

2020-08-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All patients must have undergone specified complete surgical staging.
• Patients must be surgically staged endometrial cancer patients at high-risk for recurrence.
• Patients must have adequate bone marrow, renal and hepatic function.

You may not qualify if…

• Patients with recurrent disease.
• Patients with GOG performance status of 3 or 4.

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.